{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/ja508679h.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>Photodynamic\ntherapy (PDT) is an effective anticancer procedure\nthat relies on tumor localization of a photosensitizer followed by\nlight activation to generate cytotoxic reactive oxygen species (e.g., <sup>1</sup>O<sub>2</sub>). Here we report the rational design of a Hf\u2013porphyrin\nnanoscale metal\u2013organic framework, DBP\u2013UiO, as an exceptionally\neffective photosensitizer for PDT of resistant head and neck cancer.\nDBP\u2013UiO efficiently generates <sup>1</sup>O<sub>2</sub> owing\nto site isolation of porphyrin ligands, enhanced intersystem crossing\nby heavy Hf centers, and facile <sup>1</sup>O<sub>2</sub> diffusion\nthrough porous DBP\u2013UiO nanoplates. Consequently, DBP\u2013UiO\ndisplayed greatly enhanced PDT efficacy both <italic toggle=\"yes\">in vitro</italic> and <italic toggle=\"yes\">in vivo</italic>, leading to complete tumor eradication\nin half of the mice receiving a single DBP\u2013UiO dose and a single\nlight exposure. NMOFs thus represent a new class of highly potent\nPDT agents and hold great promise in treating resistant cancers in\nthe clinic.</p>", "clean_text": "Photodynamic therapy (PDT) is an effective anticancer procedure that relies on tumor localization of a photosensitizer followed by light activation to generate cytotoxic reactive oxygen species (e.g., 1O2). Here we report the rational design of a Hf-porphyrin nanoscale metal-organic framework, DBP-UiO, as an exceptionally effective photosensitizer for PDT of resistant head and neck cancer. DBP-UiO efficiently generates 1O2 owing to site isolation of porphyrin ligands, enhanced intersystem crossing by heavy Hf centers, and facile 1O2 diffusion through porous DBP-UiO nanoplates. Consequently, DBP-UiO displayed greatly enhanced PDT efficacy both in vitro and in vivo, leading to complete tumor eradication in half of the mice receiving a single DBP-UiO dose and a single light exposure. NMOFs thus represent a new class of highly potent PDT agents and hold great promise in treating resistant cancers in the clinic.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>Photodynamic therapy (PDT) is\na phototherapy that combines three nontoxic components, a photosensitizer\n(PS), a light source, and tissue oxygen, to cause toxicity to malignant\nand other diseased cells. The mechanism\nof PDT involves energy transfer from the light-excited PS to oxygen\nand other molecules in the tissue to generate reactive oxygen species\n(ROS), particularly, singlet oxygen (<sup>1</sup>O<sub>2</sub>), which\ninduces cellular toxicity. PDT can lead to localized\ndestruction of diseased tissues via selective uptake of the PS and/or\nlocal exposure to light, providing a minimally invasive cancer therapy.\nThe application of PDT in cancer treatment dates back to 1970s when\nhematoporphyrin derivatives were studied for PDT efficacy <italic toggle=\"yes\">in vivo</italic>, and the first PDT agent\nphotofrin was approved for clinical use in 1993. Most clinically used\nPSs are from the porphyrin family, with a few other dyes emerging\nas efficient PSs in recent years.\n</p>", "clean_text": "Photodynamic therapy (PDT) is a phototherapy that combines three nontoxic components, a photosensitizer (PS), a light source, and tissue oxygen, to cause toxicity to malignant and other diseased cells. The mechanism of PDT involves energy transfer from the light-excited PS to oxygen and other molecules in the tissue to generate reactive oxygen species (ROS), particularly, singlet oxygen (1O2), which induces cellular toxicity. PDT can lead to localized destruction of diseased tissues via selective uptake of the PS and/or local exposure to light, providing a minimally invasive cancer therapy. The application of PDT in cancer treatment dates back to 1970s when hematoporphyrin derivatives were studied for PDT efficacy in vivo, and the first PDT agent photofrin was approved for clinical use in 1993. Most clinically used PSs are from the porphyrin family, with a few other dyes emerging as efficient PSs in recent years. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<p>Selective localization of PSs in tumors is critical for effective\nPDT. However, many PSs are hydrophobic in nature, which not only leads\nto insufficient tumor localization but also causes PS aggregation\nto diminish the PDT efficacy. Significant\nsynthetic modifications are thus needed to render these PSs effective\nPDT agents <italic toggle=\"yes\">in vivo</italic>. An alternative approach is to\nuse nanocarriers to selectively deliver therapeutic or PDT agents\nto tumors via the enhanced permeation and retention (EPR) effect and\nsome times via active tumor targeting with ligands that bind to overexpressed\nreceptors in cancers. Indeed, a number of nanoparticle\nplatforms have been developed to deliver molecule- or material-based\nPDT and photothermal agents to cancers; and in some cases, encouraging\nclinical data are emerging.\n</p>", "clean_text": "Selective localization of PSs in tumors is critical for effective PDT. However, many PSs are hydrophobic in nature, which not only leads to insufficient tumor localization but also causes PS aggregation to diminish the PDT efficacy. Significant synthetic modifications are thus needed to render these PSs effective PDT agents in vivo. An alternative approach is to use nanocarriers to selectively deliver therapeutic or PDT agents to tumors via the enhanced permeation and retention (EPR) effect and some times via active tumor targeting with ligands that bind to overexpressed receptors in cancers. Indeed, a number of nanoparticle platforms have been developed to deliver molecule- or material-based PDT and photothermal agents to cancers; and in some cases, encouraging clinical data are emerging. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>Nanoscale\nmetal\u2013organic frameworks (NMOFs), constructed\nfrom metal ion/ion clusters and organic bridging ligands, have recently\nemerged as a promising nanocarrier platform for therapeutic and imaging\nagents. Compared to other nanocarriers,\nNMOFs combine many beneficial features into a single delivery platform,\nincluding tunable chemical compositions and crystalline structures;\nhigh porosity; and biodegradability. For example, we used a NMOF to\ndeliver both cisplatin (in the pores) and siRNAs (on the surface)\nto overcome drug resistance in ovarian cancer, and more recently, we demonstrated real-time intracellular\npH sensing in live cells with a fluorescent NMOF by taking advantage\nof its crystalline and porous structure.\n</p>", "clean_text": "Nanoscale metal-organic frameworks (NMOFs), constructed from metal ion/ion clusters and organic bridging ligands, have recently emerged as a promising nanocarrier platform for therapeutic and imaging agents. Compared to other nanocarriers, NMOFs combine many beneficial features into a single delivery platform, including tunable chemical compositions and crystalline structures; high porosity; and biodegradability. For example, we used a NMOF to deliver both cisplatin (in the pores) and siRNAs (on the surface) to overcome drug resistance in ovarian cancer, and more recently, we demonstrated real-time intracellular pH sensing in live cells with a fluorescent NMOF by taking advantage of its crystalline and porous structure. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>Here we report the design of a Hf\u2013porphyrin NMOF as\na highly\neffective PS for PDT of resistant head and neck cancer. Although porphyrin-based\nMOFs have been intensively studied, the\ndelivery of PDT agents using porphyrin-based NMOFs has not been realized.\nWe hypothesized that the incorporation of a porphyrin-derived bridging\nligand into a robust and porous UiO NMOF structure with proper morphologies\nand dimensions would have several advantages over existing nanoparticle\nPDT agents: first, the PS molecules are well-isolated in the framework\nto avoid aggregation and self-quenching of the excited states; second,\ncoordination of porphyrin ligands to heavy Hf centers via the carboxylate\ngroups can promote intersystem crossing to enhance ROS generation\nefficiency; third, the porous NMOF structure provides a pathway for\nfacile diffusion of ROS (such as <sup>1</sup>O<sub>2</sub>) out of\nthe NMOF interior to exert their cytotoxic effects on cancer cells.\nIn this NMOF design, an unprecedentedly high PS loading can be achieved\nto enable highly effective PDT of difficult-to-treat cancers.</p>", "clean_text": "Here we report the design of a Hf-porphyrin NMOF as a highly effective PS for PDT of resistant head and neck cancer. Although porphyrin-based MOFs have been intensively studied, the delivery of PDT agents using porphyrin-based NMOFs has not been realized. We hypothesized that the incorporation of a porphyrin-derived bridging ligand into a robust and porous UiO NMOF structure with proper morphologies and dimensions would have several advantages over existing nanoparticle PDT agents: first, the PS molecules are well-isolated in the framework to avoid aggregation and self-quenching of the excited states; second, coordination of porphyrin ligands to heavy Hf centers via the carboxylate groups can promote intersystem crossing to enhance ROS generation efficiency; third, the porous NMOF structure provides a pathway for facile diffusion of ROS (such as 1O2) out of the NMOF interior to exert their cytotoxic effects on cancer cells. In this NMOF design, an unprecedentedly high PS loading can be achieved to enable highly effective PDT of difficult-to-treat cancers.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>The new porphyrin derivative, 5,15-di\u00ad(<italic toggle=\"yes\">p</italic>-benzoato)\u00adporphyrin\n(H<sub>2</sub>DBP), was synthesized by a condensation reaction between\n4-(methoxycarbonyl)\u00adbenzaldehyde and dipyrrylmethane, and characterized\nby <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy and mass spectrometry\n(Figures S3\u2013S5,  [SI]). The linearly aligned dicarboxylate groups of the DBP ligand\nallow the construction of a DBP\u2013UiO NMOF with the framework\nformula of Hf<sub>6</sub>(\u03bc<sub>3</sub>-O)<sub>4</sub>(\u03bc<sub>3</sub>-OH)<sub>4</sub>(DBP)<sub>6</sub>. DBP\u2013UiO was synthesized\nby a solvothermal reaction between HfCl<sub>4</sub> and H<sub>2</sub>DBP in <italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>-dimethylformamide (DMF)\nat 80 \u00b0C (Scheme ). The resulting dark\npurple powder was washed with copious amounts of DMF, 1% triethylamine\nin ethanol (v/v), and ethanol successively before being dispersed\nin ethanol as a stock suspension.</p>", "clean_text": "The new porphyrin derivative, 5,15-di(p-benzoato)porphyrin (H2DBP), was synthesized by a condensation reaction between 4-(methoxycarbonyl)benzaldehyde and dipyrrylmethane, and characterized by 1H and 13C NMR spectroscopy and mass spectrometry (Figures S3-S5,  [SI]). The linearly aligned dicarboxylate groups of the DBP ligand allow the construction of a DBP-UiO NMOF with the framework formula of Hf6(\u03bc3-O)4(\u03bc3-OH)4(DBP)6. DBP-UiO was synthesized by a solvothermal reaction between HfCl4 and H2DBP in N,N-dimethylformamide (DMF) at 80 \u00b0C (Scheme ). The resulting dark purple powder was washed with copious amounts of DMF, 1% triethylamine in ethanol (v/v), and ethanol successively before being dispersed in ethanol as a stock suspension.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Synthesis of Hf\u2013DBP NMOF and\nthe Schematic Description of\nSinglet Oxygen Generation Process</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0004.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 1  Synthesis of Hf-DBP NMOF and the Schematic Description of Singlet Oxygen Generation Process   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<p>Numerous attempts failed to grow DBP\u2013UiO crystals\nsuitable\nfor single-crystal X-ray diffraction. Fortunately, we have determined\nthe single crystal structure of an analogue of DBP\u2013UiO, Zr<sub>6</sub>(\u03bc<sub>3</sub>-O)<sub>4</sub>(\u03bc<sub>3</sub>-OH)<sub>4</sub>(Zn\u2013DPDBP)<sub>6</sub> (Zn\u2013DPDBP\u2013UiO,\nDPDBP is 5,15-di\u00ad(<italic toggle=\"yes\">p</italic>-benzoato)-10,20-diphenyl-porphyrin\nand has the same length as DBP; Table S1 and Figure S6, ), whose powder X-ray diffraction (PXRD) pattern\nis essentially the same as that of DBP\u2013UiO (Figure a). DBP\u2013UiO thus adopts a UiO-type MOF structure\nthat is built from 12-connected Hf<sub>6</sub>(\u03bc<sub>3</sub>-O)<sub>4</sub>(\u03bc<sub>3</sub>-OH)<sub>4</sub> secondary building\nunits (SBUs) and DBP bridging ligands. DBP\u2013UiO has a very open framework structure with triangular\nchannels of 1.6 nm in dimensions as well as octahedral and tetrahedral\ncavities of 2.8 and 2.0 nm in dimensions, respectively.</p>", "clean_text": "Numerous attempts failed to grow DBP-UiO crystals suitable for single-crystal X-ray diffraction. Fortunately, we have determined the single crystal structure of an analogue of DBP-UiO, Zr6(\u03bc3-O)4(\u03bc3-OH)4(Zn-DPDBP)6 (Zn-DPDBP-UiO, DPDBP is 5,15-di(p-benzoato)-10,20-diphenyl-porphyrin and has the same length as DBP; Table S1 and Figure S6, ), whose powder X-ray diffraction (PXRD) pattern is essentially the same as that of DBP-UiO (Figure a). DBP-UiO thus adopts a UiO-type MOF structure that is built from 12-connected Hf6(\u03bc3-O)4(\u03bc3-OH)4 secondary building units (SBUs) and DBP bridging ligands. DBP-UiO has a very open framework structure with triangular channels of 1.6 nm in dimensions as well as octahedral and tetrahedral cavities of 2.8 and 2.0 nm in dimensions, respectively.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Morphology\nand structure of DBP\u2013UiO. (a) PXRD patterns of\nZn\u2013DPDBP\u2013UiO, DBP\u2013UiO, and DBP\u2013UiO after\nincubating in RPMI 1640 cell culture medium for 12 h. (b) TEM image\nof DBP\u2013UiO showing nanoplate morphology; high-resolution TEM\nimages of DBP\u2013UiO samples before (c) and after (e) cell-medium\ncultivation, and their fast Fourier transform patterns (d,f), respectively.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0001.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 1  Morphology and structure of DBP-UiO. (a) PXRD patterns of Zn-DPDBP-UiO, DBP-UiO, and DBP-UiO after incubating in RPMI 1640 cell culture medium for 12 h. (b) TEM image of DBP-UiO showing nanoplate morphology; high-resolution TEM images of DBP-UiO samples before (c) and after (e) cell-medium cultivation, and their fast Fourier transform patterns (d,f), respectively.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "text", "classification": ["property"], "content": "<p>DBP\u2013UiO particles display\na plate morphology by transmission\nelectron microscopy (TEM) (Figure b and Figure\nS7, ). Nitrogen adsorption measurements\ngave a BET surface area of 558 m<sup>2</sup>/g for DBP\u2013UiO\n(Figure S8, ). The composition of DBP\u2013UiO\nwas confirmed by thermogravimetric analysis (Figure S9, ) and inductively coupled plasma\u2013mass\nspectrometry (ICP\u2013MS), giving DBP loading of 77 wt % (calcd\n73%) and Hf content of 24.3% (calcd 23.7%), respectively. These results\nalso indicate that DBP ligands do not coordinate to Hf<sup>4+</sup> ions via nitrogen atoms during the UiO synthesis (the Hf content\nwould have been 37.2% if all DBP ligands were metalated).</p>", "clean_text": "DBP-UiO particles display a plate morphology by transmission electron microscopy (TEM) (Figure b and Figure S7, ). Nitrogen adsorption measurements gave a BET surface area of 558 m2/g for DBP-UiO (Figure S8, ). The composition of DBP-UiO was confirmed by thermogravimetric analysis (Figure S9, ) and inductively coupled plasma-mass spectrometry (ICP-MS), giving DBP loading of 77 wt % (calcd 73%) and Hf content of 24.3% (calcd 23.7%), respectively. These results also indicate that DBP ligands do not coordinate to Hf4+ ions via nitrogen atoms during the UiO synthesis (the Hf content would have been 37.2% if all DBP ligands were metalated).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 11, "type": "text", "classification": "error", "content": "<p>Individual\nSBUs are clearly visible in high-resolution TEM images\nof DBP\u2013UiO (Figure c). The distances\nbetween SBUs are measured to be approximately 2.7 nm (Figure S10, ), which are consistent with the calculated\ndistances of 2.77 nm based on the X-ray structure model. Fast Fourier\ntransform (FFT) of the high-resolution TEM image displays a 3-fold\nsymmetry for the nanoplates (Figure d), consistent\nwith the cubic crystal system of the DBP\u2013UiO. The dimensions\nof the nanoplates are measured to be \u223c100 nm in diameter and\n\u223c10 nm in thickness. Such thin plates consist of only 4\u20135\nsets of (111) packing layer (<italic toggle=\"yes\">d</italic>\n<sub>111</sub> = 2.2\nnm). Dynamic light scattering (DLS) measurements gave an average diameter\nof 76.3 nm for the particles (Figure S11, ). Notably, the nanoplate morphology is particularly advantageous\nfor generating ROS for PDT. The diffusion length of <sup>1</sup>O<sub>2</sub> is no more than 90\u2013120 nm in aqueous environment and was estimated to be 20\u2013220 nm inside\ncells. Therefore, the nanoplates as thin\nas 10 nm in thickness are ideally suited for transporting <sup>1</sup>O<sub>2</sub> from the NMOF interior to the cell cytoplasm to exert\ncytotoxic effects.</p>", "clean_text": "Individual SBUs are clearly visible in high-resolution TEM images of DBP-UiO (Figure c). The distances between SBUs are measured to be approximately 2.7 nm (Figure S10, ), which are consistent with the calculated distances of 2.77 nm based on the X-ray structure model. Fast Fourier transform (FFT) of the high-resolution TEM image displays a 3-fold symmetry for the nanoplates (Figure d), consistent with the cubic crystal system of the DBP-UiO. The dimensions of the nanoplates are measured to be ~100 nm in diameter and ~10 nm in thickness. Such thin plates consist of only 4-5 sets of (111) packing layer (d 111 = 2.2 nm). Dynamic light scattering (DLS) measurements gave an average diameter of 76.3 nm for the particles (Figure S11, ). Notably, the nanoplate morphology is particularly advantageous for generating ROS for PDT. The diffusion length of 1O2 is no more than 90-120 nm in aqueous environment and was estimated to be 20-220 nm inside cells. Therefore, the nanoplates as thin as 10 nm in thickness are ideally suited for transporting 1O2 from the NMOF interior to the cell cytoplasm to exert cytotoxic effects.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<p>The UiO framework was recently shown to be\nstable in aqueous solution. DBP\u2013UiO was\nincubated in RPMI 1640 cell culture medium for\n12 h to determine its stability in physiologically relevant media.\nTEM images showed an unaltered morphology of the nanoplates, and FFT\nproved that the crystalline structure of DBP\u2013UiO remained intact\n(Figures e,f and S12, ). The PXRD patterns of the NMOF samples before and after\nincubation in RPMI 1640 medium are identical (Figure a), further confirming structural stability of DBP\u2013UiO\nin physiological environments.</p>", "clean_text": "The UiO framework was recently shown to be stable in aqueous solution. DBP-UiO was incubated in RPMI 1640 cell culture medium for 12 h to determine its stability in physiologically relevant media. TEM images showed an unaltered morphology of the nanoplates, and FFT proved that the crystalline structure of DBP-UiO remained intact (Figures e,f and S12, ). The PXRD patterns of the NMOF samples before and after incubation in RPMI 1640 medium are identical (Figure a), further confirming structural stability of DBP-UiO in physiological environments.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": "error", "content": "<p>The UV\u2013visible absorption\nspectra of H<sub>2</sub>DBP and\nDBP\u2013UiO in phosphate buffer saline (PBS) buffers (pH = 7.4)\nare compared in Figure a. H<sub>2</sub>DBP\nshows a Soret band at 402 nm and four Q-bands at 505, 540, 566, and\n619 nm. The extinction coefficients of H<sub>2</sub>DBP at 402 and\n619 nm are 2.2 \u00d7 10<sup>5</sup> and 1.7 \u00d7 10<sup>3</sup> M<sup>\u20131</sup> cm<sup>\u20131</sup>, respectively (Figures\nS13 and 14, ). DBP\u2013UiO shows slight\nred shifts for all Q-bands, with the peaks appearing at 510, 544,\n579, and 634 nm. The red-shifts probably result from the coordination\nof the carboxylate groups of DBP ligands to Hf<sup>4+</sup> centers.\nThe presence of four Q-bands and their red shifts further support\nthe presence of free-base porphyrin ligands in DBP\u2013UiO. The\nSoret band of DBP\u2013UiO is significantly broadened, presumably\ndue to inequivalent ligand environments in thin nanoplates as well\nas potential framework distortion in thin MOF structures.</p>", "clean_text": "The UV-visible absorption spectra of H2DBP and DBP-UiO in phosphate buffer saline (PBS) buffers (pH = 7.4) are compared in Figure a. H2DBP shows a Soret band at 402 nm and four Q-bands at 505, 540, 566, and 619 nm. The extinction coefficients of H2DBP at 402 and 619 nm are 2.2 \u00d7 105 and 1.7 \u00d7 103 M-1 cm-1, respectively (Figures S13 and 14, ). DBP-UiO shows slight red shifts for all Q-bands, with the peaks appearing at 510, 544, 579, and 634 nm. The red-shifts probably result from the coordination of the carboxylate groups of DBP ligands to Hf4+ centers. The presence of four Q-bands and their red shifts further support the presence of free-base porphyrin ligands in DBP-UiO. The Soret band of DBP-UiO is significantly broadened, presumably due to inequivalent ligand environments in thin nanoplates as well as potential framework distortion in thin MOF structures.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 14, "type": "text", "classification": "error", "content": "<p>Singlet\noxygen generation efficiencies of H<sub>2</sub>DBP and\nDBP\u2013UiO were determined using Singlet Oxygen Sensor Green (SOSG,\nLife Technologies). After exposure to a LED light source (peak emission\nat 640 nm and energy irradiance of 100 mW/cm<sup>2</sup>; Figure S17, ), the chemiluminescent reagent SOSG reacted\nwith <sup>1</sup>O<sub>2</sub> to generate green fluorescence, which\nwas quantified with a fluorimeter. The fluorescence intensity was\nplotted against irradiation time (Figure b).\nThe <sup>1</sup>O<sub>2</sub> generation was depicted with an exponential\nfunction that corresponded to a pseudo first-order process. The <sup>1</sup>O<sub>2</sub> generation curve was fitted with the following\nequation:<disp-formula id=\"eq1\">\n<label>1</label>\n<alternatives>\n<graphic orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_m001.gif\" xlink:type=\"simple\"></graphic>\n<mml:math display=\"block\">\n<mml:msub>\n<mml:mrow>\n<mml:mi>I</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">F</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo>=</mml:mo>\n<mml:mi>A</mml:mi>\n<mml:mrow>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:mn>1</mml:mn>\n<mml:mo>\u2212</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">e</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mo>\u2212</mml:mo>\n<mml:mi>k</mml:mi>\n<mml:mi>t</mml:mi>\n</mml:mrow>\n</mml:msup>\n<mml:mo stretchy=\"false\">)</mml:mo>\n</mml:mrow>\n</mml:math>\n</alternatives>\n</disp-formula>where <italic toggle=\"yes\">I</italic>\n<sub>F</sub> is fluorescence\nintensity and <italic toggle=\"yes\">t</italic> represents irradiation time, while <italic toggle=\"yes\">A</italic> and <italic toggle=\"yes\">k</italic> are fitting parameters (for detailed\nderivations, see ). The fitted equations\nfor H<sub>2</sub>DBP and DBP\u2013UiO are (Table S3, )\u00ad<disp-formula id=\"eq2\">\n<label>2</label>\n<alternatives>\n<graphic orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_m002.gif\" xlink:type=\"simple\"></graphic>\n<mml:math display=\"block\">\n<mml:msub>\n<mml:mrow>\n<mml:mi>I</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">H</mml:mi>\n<mml:mn>2</mml:mn>\n<mml:mi>DBP</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo>=</mml:mo>\n<mml:mn>68</mml:mn>\n<mml:mo>\u00d7</mml:mo>\n<mml:mrow>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:mn>1</mml:mn>\n<mml:mo>\u2212</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">e</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mo>\u2212</mml:mo>\n<mml:mn>0.0015</mml:mn>\n<mml:mi>t</mml:mi>\n</mml:mrow>\n</mml:msup>\n<mml:mo stretchy=\"false\">)</mml:mo>\n</mml:mrow>\n</mml:math>\n</alternatives>\n</disp-formula>\n<disp-formula id=\"eq3\">\n<label>3</label>\n<alternatives>\n<graphic orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_m003.gif\" xlink:type=\"simple\"></graphic>\n<mml:math display=\"block\">\n<mml:msub>\n<mml:mrow>\n<mml:mi>I</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi>DBP</mml:mi>\n<mml:mo>\u2212</mml:mo>\n<mml:mi>UiO</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo>=</mml:mo>\n<mml:mn>88</mml:mn>\n<mml:mo>\u00d7</mml:mo>\n<mml:mrow>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:mn>1</mml:mn>\n<mml:mo>\u2212</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">e</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mo>\u2212</mml:mo>\n<mml:mn>0.0033</mml:mn>\n<mml:mi>t</mml:mi>\n</mml:mrow>\n</mml:msup>\n<mml:mo stretchy=\"false\">)</mml:mo>\n</mml:mrow>\n</mml:math>\n</alternatives>\n</disp-formula>\n</p>", "clean_text": "Singlet oxygen generation efficiencies of H2DBP and DBP-UiO were determined using Singlet Oxygen Sensor Green (SOSG, Life Technologies). After exposure to a LED light source (peak emission at 640 nm and energy irradiance of 100 mW/cm2; Figure S17, ), the chemiluminescent reagent SOSG reacted with 1O2 to generate green fluorescence, which was quantified with a fluorimeter. The fluorescence intensity was plotted against irradiation time (Figure b). The 1O2 generation was depicted with an exponential function that corresponded to a pseudo first-order process. The 1O2 generation curve was fitted with the following equation: 1      I   F   = A  ( 1 -   e   - k t   )    where I F is fluorescence intensity and t represents irradiation time, while A and k are fitting parameters (for detailed derivations, see ). The fitted equations for H2DBP and DBP-UiO are (Table S3, ) 2      I   H 2 DBP   = 68 \u00d7  ( 1 -   e   - 0.0015 t   )      3      I   DBP - UiO   = 88 \u00d7  ( 1 -   e   - 0.0033 t   )     ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>(a) Absorption\nspectra of H<sub>2</sub>DBP and DBP\u2013UiO in\nPBS. (b) Singlet oxygen generation by DBP\u2013UiO, H<sub>2</sub>DBP, and H<sub>2</sub>DBP + HfCl<sub>4</sub>. The dots are experimental\ndata and the solid lines are fitted curves. (c) Time-resolved fluorescent\ndecay traces of H<sub>2</sub>DBP and DBP\u2013UiO along with instrument\nresponse function (IRF). (d) <italic toggle=\"yes\">In vitro</italic> PDT cytotoxicity\nof H<sub>2</sub>DBP, DBP\u2013UiO, and PpIX at different PS concentrations\nand irradiation times.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0002.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 2  (a) Absorption spectra of H2DBP and DBP-UiO in PBS. (b) Singlet oxygen generation by DBP-UiO, H2DBP, and H2DBP + HfCl4. The dots are experimental data and the solid lines are fitted curves. (c) Time-resolved fluorescent decay traces of H2DBP and DBP-UiO along with instrument response function (IRF). (d) In vitro PDT cytotoxicity of H2DBP, DBP-UiO, and PpIX at different PS concentrations and irradiation times.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 16, "type": "text", "classification": "error", "content": "<p>The product of <italic toggle=\"yes\">Ak</italic> in the equation is proportional\nto the initial rate of the reaction that indicates the <sup>1</sup>O<sub>2</sub> generation efficiency (see discussion in ). DBP\u2013UiO is thus at least twice as\nefficient as H<sub>2</sub>DBP in generating <sup>1</sup>O<sub>2</sub>, presumably owing to heavy Hf<sup>4+</sup> centers facilitating\nthe intersystem crossing from the <sup>1</sup>DBP to <sup>3</sup>DBP\nexcite state. Consistent with this, the <sup>1</sup>DBP emission intensity at 640 nm greatly diminished for DBP\u2013UiO\n(by a factor of \u223c250; Figure S15, ) with a lifetime reduction from 10.9 ns for H<sub>2</sub>DBP to\n0.26 ns for DBP\u2013UiO (Figures c and\nS16 and Table S2, ). As a control, addition\nof Hf<sup>4+</sup> to the H<sub>2</sub>DBP ligand solution did not\nenhance but rather reduce the generation of <sup>1</sup>O<sub>2</sub> (Figure b).</p>", "clean_text": "The product of Ak in the equation is proportional to the initial rate of the reaction that indicates the 1O2 generation efficiency (see discussion in ). DBP-UiO is thus at least twice as efficient as H2DBP in generating 1O2, presumably owing to heavy Hf4+ centers facilitating the intersystem crossing from the 1DBP to 3DBP excite state. Consistent with this, the 1DBP emission intensity at 640 nm greatly diminished for DBP-UiO (by a factor of ~250; Figure S15, ) with a lifetime reduction from 10.9 ns for H2DBP to 0.26 ns for DBP-UiO (Figures c and S16 and Table S2, ). As a control, addition of Hf4+ to the H2DBP ligand solution did not enhance but rather reduce the generation of 1O2 (Figure b).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 17, "type": "text", "classification": ["else"], "content": "<p>Encouraged by the excellent <sup>1</sup>O<sub>2</sub> generation\nefficiency, we tested the PDT efficacy of DBP\u2013UiO on resistant\nhead and neck cancer. Head and neck cancer refers to a group of biologically\nsimilar cancers that arise in the head or neck region (including nasal\ncavity, sinuses, lips, mouth, salivary glands, throat, and larynx).\nCurrent treatments of head and neck cancers include surgery and radiation\ntherapy, with chemotherapy and chemoradiotherapy playing some roles. Since head and neck cancers occur superficially,\nPDT represents a viable alternative treatment modality.\n</p>", "clean_text": "Encouraged by the excellent 1O2 generation efficiency, we tested the PDT efficacy of DBP-UiO on resistant head and neck cancer. Head and neck cancer refers to a group of biologically similar cancers that arise in the head or neck region (including nasal cavity, sinuses, lips, mouth, salivary glands, throat, and larynx). Current treatments of head and neck cancers include surgery and radiation therapy, with chemotherapy and chemoradiotherapy playing some roles. Since head and neck cancers occur superficially, PDT represents a viable alternative treatment modality. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 18, "type": "text", "classification": ["else"], "content": "<p>\n<italic toggle=\"yes\">In vitro</italic> PDT was performed\non human head and neck\ncancer cells SQ20B, which are resistant to cisplatin and radiation\ntherapy. The tumor cell uptake of DBP\u2013UiO was first evaluated\nby incubating SQ20B cells with DBP\u2013UiO (30 \u03bcg/mL) for\n4 or 12 h (Figure S20, ). The Hf concentrations\nin the cells were determined by ICP\u2013MS. No significant difference\nwas observed between the cells after 4 and 12 h incubations, showing\nrapid internalization of DBP\u2013UiO by cancer cells.</p>", "clean_text": " In vitro PDT was performed on human head and neck cancer cells SQ20B, which are resistant to cisplatin and radiation therapy. The tumor cell uptake of DBP-UiO was first evaluated by incubating SQ20B cells with DBP-UiO (30 \u03bcg/mL) for 4 or 12 h (Figure S20, ). The Hf concentrations in the cells were determined by ICP-MS. No significant difference was observed between the cells after 4 and 12 h incubations, showing rapid internalization of DBP-UiO by cancer cells.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 19, "type": "text", "classification": "error", "content": "<p>To\nfurther confirm the PDT efficacy of DBP\u2013UiO, SQ20B cancer\ncells were treated with H<sub>2</sub>DBP, DBP\u2013UiO, or protoporphyrin\nIX (PpIX) at various concentrations (5, 10, 20, 50, and 100 \u03bcM\nbased on ligand concentrations), and the cells were irradiated with\nLED light (640 nm, 100 mW/cm<sup>2</sup>) for 15 min (total light\ndose 90 J/cm<sup>2</sup>) or 30 min (total light dose 180 J/cm<sup>2</sup>), respectively. Significant PDT efficacy was observed in\nDBP\u2013UiO treated groups, even for the group receiving 5 \u03bcM\nPS dose and 15 min irradiation (Figure d).\nH<sub>2</sub>DBP-treated groups show moderate PDT efficacy only at\n20 \u03bcM dose with 30 min light irradiation, while no cytotoxicity\nwas observed in dark control or blank control groups. In comparison,\nPpIX is much less photocytotoxic than DBP\u2013UiO under similar\nconditions (Figure d).</p>", "clean_text": "To further confirm the PDT efficacy of DBP-UiO, SQ20B cancer cells were treated with H2DBP, DBP-UiO, or protoporphyrin IX (PpIX) at various concentrations (5, 10, 20, 50, and 100 \u03bcM based on ligand concentrations), and the cells were irradiated with LED light (640 nm, 100 mW/cm2) for 15 min (total light dose 90 J/cm2) or 30 min (total light dose 180 J/cm2), respectively. Significant PDT efficacy was observed in DBP-UiO treated groups, even for the group receiving 5 \u03bcM PS dose and 15 min irradiation (Figure d). H2DBP-treated groups show moderate PDT efficacy only at 20 \u03bcM dose with 30 min light irradiation, while no cytotoxicity was observed in dark control or blank control groups. In comparison, PpIX is much less photocytotoxic than DBP-UiO under similar conditions (Figure d).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 20, "type": "text", "classification": "error", "content": "<p>We carried out\nproof-of-concept <italic toggle=\"yes\">in vivo</italic> experiments\non SQ20B subcutaneous xenograft murine models to evaluate the PDT\nefficacy of DBP\u2013UiO. The mice were treated with PBS control,\nDBP\u2013UiO (3.5 mg DBP/kg), or H<sub>2</sub>DBP (3.5 mg/kg) by\nintratumoral injection. Twelve hours post injection, each mouse was\nirradiated at the tumor site with light (180 J/cm<sup>2</sup>) for\n30 min. For comparison, photofrin is administrated by intraperitoneal\ninjection at 10 mg/kg in tumor bearing mice and with light irradiation\nof 135 J/cm<sup>2</sup>. As depicted\nin Figure a, the tumors of mice treated with\nDBP\u2013UiO started shrinking 1 day post DBP\u2013UiO administration\nand PDT. Most importantly, among the four tumors in the DBP\u2013UiO\ngroup, two tumors were completely eradicated by single DBP\u2013UiO\nadministration and single light irradiation, while the sizes of the\nother two tumors decreased from \u223c150 to \u223c3 mm<sup>3</sup> (Figure b\u2013d). The tumor growth of\nmice treated with H<sub>2</sub>DBP was slightly suppressed after PDT,\nhowever, accelerated after 5 days and exhibited no difference to the\ncontrol group at the end point. After local administration, DBP\u2013UiO\ncould be efficiently internalized by the tumor cells and induce cytotoxicity\nupon irradiation, while the free ligand might be cleared away from\nthe tumor sites before irradiation. No skin/tissue damage was observed\nafter PDT treatment on all mice (Figure c).\nHistologies of tumor slices showed macrophage infiltration in tumors\nof the DBP\u2013UiO treated group and indicated that significant\nfractions of tumor cells were undergoing apoptosis/necrosis (Figure\nS21, ).</p>", "clean_text": "We carried out proof-of-concept in vivo experiments on SQ20B subcutaneous xenograft murine models to evaluate the PDT efficacy of DBP-UiO. The mice were treated with PBS control, DBP-UiO (3.5 mg DBP/kg), or H2DBP (3.5 mg/kg) by intratumoral injection. Twelve hours post injection, each mouse was irradiated at the tumor site with light (180 J/cm2) for 30 min. For comparison, photofrin is administrated by intraperitoneal injection at 10 mg/kg in tumor bearing mice and with light irradiation of 135 J/cm2. As depicted in Figure a, the tumors of mice treated with DBP-UiO started shrinking 1 day post DBP-UiO administration and PDT. Most importantly, among the four tumors in the DBP-UiO group, two tumors were completely eradicated by single DBP-UiO administration and single light irradiation, while the sizes of the other two tumors decreased from ~150 to ~3 mm3 (Figure b-d). The tumor growth of mice treated with H2DBP was slightly suppressed after PDT, however, accelerated after 5 days and exhibited no difference to the control group at the end point. After local administration, DBP-UiO could be efficiently internalized by the tumor cells and induce cytotoxicity upon irradiation, while the free ligand might be cleared away from the tumor sites before irradiation. No skin/tissue damage was observed after PDT treatment on all mice (Figure c). Histologies of tumor slices showed macrophage infiltration in tumors of the DBP-UiO treated group and indicated that significant fractions of tumor cells were undergoing apoptosis/necrosis (Figure S21, ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>\n<italic toggle=\"yes\">In vivo</italic> efficacy of PDT\non SQ20B tumor bearing\nmice. (a) Tumor growth inhibition curve after PDT treatment. Black\nand red arrows refer to injection and irradiation time points, respectively.\n(b) Tumor weight after PDT treatment. (c) Photos of the mice on Day\n8. (d) Photo of tumors of each group after PDT. Two tumors in the\nDBP\u2013UiO group were completely eradicated at the end point.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0003.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 3   In vivo efficacy of PDT on SQ20B tumor bearing mice. (a) Tumor growth inhibition curve after PDT treatment. Black and red arrows refer to injection and irradiation time points, respectively. (b) Tumor weight after PDT treatment. (c) Photos of the mice on Day 8. (d) Photo of tumors of each group after PDT. Two tumors in the DBP-UiO group were completely eradicated at the end point.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "text", "classification": "error", "content": "<p>In summary, we have designed and\nsynthesized a stable and porous\nDBP\u2013UiO NMOF with an ideal combination of structural regularity\nand nanoplate morphology for highly effective PDT of resistant head\nand neck cancer. As a result of site isolation of DBP ligands, enhanced\nintersystem crossing by Hf clusters, and facile <sup>1</sup>O<sub>2</sub> diffusion out of a porous nanoplate, the NMOF works as an\nefficient PDT photosensitizer, as demonstrated by both <sup>1</sup>O<sub>2</sub> generation efficiency measurements and <italic toggle=\"yes\">in vitro</italic> cytotoxicity assays. <italic toggle=\"yes\">In vivo</italic> PDT efficacy studies\nwith subcutaneous xenograft murine models demonstrated 50 times tumor\nvolume reduction in half of the mice and complete tumor eradication\nin the other half of the mice that were treated with DBP\u2013UiO.\nIn comparison, no therapeutic effect was observed in the mice treated\nwith H<sub>2</sub>DBP. The facile structural and compositional tunability\nof NMOFs should allow further tuning of other properties to afford\na new generation of highly potent PDT agents for treating resistant\ncancers in the clinic.</p>", "clean_text": "In summary, we have designed and synthesized a stable and porous DBP-UiO NMOF with an ideal combination of structural regularity and nanoplate morphology for highly effective PDT of resistant head and neck cancer. As a result of site isolation of DBP ligands, enhanced intersystem crossing by Hf clusters, and facile 1O2 diffusion out of a porous nanoplate, the NMOF works as an efficient PDT photosensitizer, as demonstrated by both 1O2 generation efficiency measurements and in vitro cytotoxicity assays. In vivo PDT efficacy studies with subcutaneous xenograft murine models demonstrated 50 times tumor volume reduction in half of the mice and complete tumor eradication in the other half of the mice that were treated with DBP-UiO. In comparison, no therapeutic effect was observed in the mice treated with H2DBP. The facile structural and compositional tunability of NMOFs should allow further tuning of other properties to afford a new generation of highly potent PDT agents for treating resistant cancers in the clinic.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 23, "type": "text", "classification": ["else"], "content": "<p>Experimental details for the\nsynthesis and characterization of H<sub>2</sub>DBP, DBP\u2013UiO,\nand Zn\u2013DPDBP\u2013UiO, photochemical properties and singlet\noxygen generation, cellular uptake, and <italic toggle=\"yes\">in vitro</italic> and <italic toggle=\"yes\">in vivo</italic> efficacy studies. This material is available free\nof charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\" xlink:type=\"simple\">http://pubs.acs.org</uri>.</p>", "clean_text": "Experimental details for the synthesis and characterization of H2DBP, DBP-UiO, and Zn-DPDBP-UiO, photochemical properties and singlet oxygen generation, cellular uptake, and in vitro and in vivo efficacy studies. This material is available free of charge via the Internet at http://pubs.acs.org.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<p>These authors contributed equally to this\nwork.</p><p>The authors declare no\ncompeting financial interest.</p><title>References</title>", "clean_text": "These authors contributed equally to this work.\n\nThe authors declare no competing financial interest.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": 10, "type": "text", "classification": "property", "content": "<p>DBP\u2013UiO particles display\na plate morphology by transmission\nelectron microscopy (TEM) (Figure b and Figure\nS7, ). Nitrogen adsorption measurements\ngave a BET surface area of 558 m<sup>2</sup>/g for DBP\u2013UiO\n(Figure S8, ). The composition of DBP\u2013UiO\nwas confirmed by thermogravimetric analysis (Figure S9, ) and inductively coupled plasma\u2013mass\nspectrometry (ICP\u2013MS), giving DBP loading of 77 wt % (calcd\n73%) and Hf content of 24.3% (calcd 23.7%), respectively. These results\nalso indicate that DBP ligands do not coordinate to Hf<sup>4+</sup> ions via nitrogen atoms during the UiO synthesis (the Hf content\nwould have been 37.2% if all DBP ligands were metalated).</p>", "clean_text": "DBP-UiO particles display a plate morphology by transmission electron microscopy (TEM) (Figure b and Figure S7, ). Nitrogen adsorption measurements gave a BET surface area of 558 m2/g for DBP-UiO (Figure S8, ). The composition of DBP-UiO was confirmed by thermogravimetric analysis (Figure S9, ) and inductively coupled plasma-mass spectrometry (ICP-MS), giving DBP loading of 77 wt % (calcd 73%) and Hf content of 24.3% (calcd 23.7%), respectively. These results also indicate that DBP ligands do not coordinate to Hf4+ ions via nitrogen atoms during the UiO synthesis (the Hf content would have been 37.2% if all DBP ligands were metalated).", "data": [[[{"meta": {"name": "DBP-UiO", "symbol": "", "chemical formula": ""}, "surface area": [{"type": "BET", "probe": "Nitrogen", "value": "558", "unit": "m2/g", "condition": ""}]}]]], "include_properties": ["surface_area"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['surface_area']", "text-property-extract": "```JSON\n[{\"meta\":{\"name\":\"DBP-UiO\", \"symbol\":\"\", \"chemical formula\":\"\"}, \"surface area\": [{\"type\": \"BET\", \"probe\": \"Nitrogen\", \"value\": \"558\", \"unit\": \"m2/g\", \"condition\": \"\"}]}]\n```"}}, {"idx": 7, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Synthesis of Hf\u2013DBP NMOF and\nthe Schematic Description of\nSinglet Oxygen Generation Process</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0004.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 1  Synthesis of Hf-DBP NMOF and the Schematic Description of Singlet Oxygen Generation Process   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Morphology\nand structure of DBP\u2013UiO. (a) PXRD patterns of\nZn\u2013DPDBP\u2013UiO, DBP\u2013UiO, and DBP\u2013UiO after\nincubating in RPMI 1640 cell culture medium for 12 h. (b) TEM image\nof DBP\u2013UiO showing nanoplate morphology; high-resolution TEM\nimages of DBP\u2013UiO samples before (c) and after (e) cell-medium\ncultivation, and their fast Fourier transform patterns (d,f), respectively.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0001.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 1  Morphology and structure of DBP-UiO. (a) PXRD patterns of Zn-DPDBP-UiO, DBP-UiO, and DBP-UiO after incubating in RPMI 1640 cell culture medium for 12 h. (b) TEM image of DBP-UiO showing nanoplate morphology; high-resolution TEM images of DBP-UiO samples before (c) and after (e) cell-medium cultivation, and their fast Fourier transform patterns (d,f), respectively.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>(a) Absorption\nspectra of H<sub>2</sub>DBP and DBP\u2013UiO in\nPBS. (b) Singlet oxygen generation by DBP\u2013UiO, H<sub>2</sub>DBP, and H<sub>2</sub>DBP + HfCl<sub>4</sub>. The dots are experimental\ndata and the solid lines are fitted curves. (c) Time-resolved fluorescent\ndecay traces of H<sub>2</sub>DBP and DBP\u2013UiO along with instrument\nresponse function (IRF). (d) <italic toggle=\"yes\">In vitro</italic> PDT cytotoxicity\nof H<sub>2</sub>DBP, DBP\u2013UiO, and PpIX at different PS concentrations\nand irradiation times.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0002.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 2  (a) Absorption spectra of H2DBP and DBP-UiO in PBS. (b) Singlet oxygen generation by DBP-UiO, H2DBP, and H2DBP + HfCl4. The dots are experimental data and the solid lines are fitted curves. (c) Time-resolved fluorescent decay traces of H2DBP and DBP-UiO along with instrument response function (IRF). (d) In vitro PDT cytotoxicity of H2DBP, DBP-UiO, and PpIX at different PS concentrations and irradiation times.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>\n<italic toggle=\"yes\">In vivo</italic> efficacy of PDT\non SQ20B tumor bearing\nmice. (a) Tumor growth inhibition curve after PDT treatment. Black\nand red arrows refer to injection and irradiation time points, respectively.\n(b) Tumor weight after PDT treatment. (c) Photos of the mice on Day\n8. (d) Photo of tumors of each group after PDT. Two tumors in the\nDBP\u2013UiO group were completely eradicated at the end point.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"ja-2014-08679h_0003.tif\" xlink:type=\"simple\"></graphic>\n</fig>", "clean_text": " 3   In vivo efficacy of PDT on SQ20B tumor bearing mice. (a) Tumor growth inhibition curve after PDT treatment. Black and red arrows refer to injection and irradiation time points, respectively. (b) Tumor weight after PDT treatment. (c) Photos of the mice on Day 8. (d) Photo of tumors of each group after PDT. Two tumors in the DBP-UiO group were completely eradicated at the end point.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/ja508679h", "title": "\nNanoscale\nMetal\u2013Organic Framework for Highly\nEffective Photodynamic Therapy of Resistant Head and Neck Cancer\n", "journal": "American Chemical\nSociety", "date": "2014.11", "author_list": ["Lu\nKuangda", "He\nChunbai", "Lin\nWenbin"]}}